Clinical Trial Update: Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating whole-body diffusion MRI for staging, predicting response, and detecting recurrence in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Ovarian Carcinoma | NA | Status: COMPLETED